Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Germany
Keywords: HLA matching; transplantation
Gillich et al. [1] report on an excellent transplant success rate of 77 kidney grafts performed over a 10-year period, using cadaver donor organs that were obtained and transplanted locally, without taking HLA matching into consideration. They hypothesize that the good result was due to the fact that the kidneys were not exposed to prolonged ischaemic preservation. Paired kidneys that were shipped to other centres via the auspices of Eurotransplant were exposed to cold ischaemia on average 10 h longer. Although the graft success rate of these kidneys was similar, they were transplanted into recipients with significantly fewer HLA mismatches. The authors suggest that the longer exposure of shipped kidneys to cold ischaemia probably abolished any advantages conferred by better HLA compatibility.
The report of Gillich et al. [1] raises a question that is not new but nevertheless highly relevant: would it make sense to concentrate with high priority on keeping the ischaemic preservation time very short, thereby limiting ischaemic damage and allowing the successful transplantation of cadaver kidneys in spite of poor HLA compatibility? If the answer were yes, the implications would be far reaching. Current cadaver kidney allocation practices would have to be revised.
Any decision favouring an overriding importance of short cold ischaemia must be based on solid facts. The study by Gillich et al. [1], although carefully conducted, was based on a rather small number of transplants. On the other hand, as pointed out by the authors, they are not alone with their view and others have argued along similar lines. Against this background, it is useful to examine the available evidence. Data presented here are derived from the Collaborative Transplant Study (CTS), the largest international scientific transplant database [2].
Surprisingly, when the influence of cold ischaemic preservation time on graft survival is examined for cadaver kidney transplants performed from 1985 to 2000, one does not find that graft outcome is directly correlated with the length of ischaemia. While there is a strong general trend towards impaired outcome with increasing preservation times, the very shortest ischaemia category (06 h) shows a paradoxical result: graft outcome in this group is significantly worse than that with donor kidneys exposed to 724 h of ischaemia (P<0.0001) (Figure 1). This result was consistent in a subset analysis of transplants performed in Europe, North America, or on other continents (not shown). Importantly, the distribution of HLA-A+B+DR mismatches was less favourable in the 06 h group than in the 724 h group. Among transplants with 06 h of cold ischaemia, there were 8.0% grafts with 01 mismatches and 22.2% with 56 mismatches, whereas the corresponding rates were 15.4% and 13.1%, respectively, among transplants with 724 h of cold ischaemia (P<0.0001).
|
|
|
A recent CTS evaluation of transplants performed from 1996 to 1999 showed that immunosuppressive treatment with modern drugs is able to decrease the early graft failure rate of poorly matched grafts. However, 3 years after transplantation, the effect of HLA matching was just as strong as that seen with application of previously standard medication [4]. In other words, rejection of HLA poorly matched grafts was delayed but not eliminated. Still, the result suggests that improved immunosuppression can overcome the effect of HLA mismatching to a greater extent. In future, the introduction of even more effective immunosuppressive regimens may well make HLA matching superfluous. For the time being, however, a continuation of strategies aimed at obtaining good HLA matches would seem sound. The CTS experience indicates that kidney preservation times in excess of 24 h should be avoided.
Editor's note
Please see also Original Article by Gillich et al., pp. 884886.
Notes
Correspondence and offprint requests to: Dr Gerhard Opelz, Institute of Immunology, University of Heidelberg, Im Neuenheimer Feld 305, D-69120 Heidelberg, Germany. Email: gerhard_opelz{at}med.uni\|[hyphen]\|heidelberg.de
References